Grant opportunity preview

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Offered by National Institutes of Health

EducationNationalAugust 11, 2027

Opportunity summary

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs…

Sign in to review full eligibility requirements, application details, matching insights, and verified source links.

Potential award

$150,000

A free Grantclient account is required.